McAndrews and Managing IP to Host Web Seminar on Successful Resolution Strategies for IP Disputes
08.22.14
McAndrews, in association with Managing IP magazine, will host a complimentary web seminar titled “Successful Early Resolution Strategies for IP Disputes,” on September 10, 2014, at 11:00 am EST. Featured speakers include McAndrews partners Edward A. Mas II and Leland G. Hansen, along with Managing IP Editor James Nurton (moderator) and Hewlett-Packard’s IP Litigation Manager Vaishali Udupa.
As litigation becomes increasingly expensive and prolonged, early resolution strategies are increasingly attractive to IP managers. IP has never been more valuable to an organization, but without the correct enforcement and resolution strategies, IP disputes can become a heavy burden on budgets. Thus, having a better understanding of successful early resolution strategies will enable companies to save money and discover mutually beneficial solutions for IP owners and accused infringers.
The seminar will cover the following topics:
- The importance of preparation
- How to select an appropriate forum
- Assessment of litigation costs and potential exposure
- Identifying potential counterclaims
- How to conduct early discovery and avoid delays
- Ways to file an early motion for summary judgment
- The utility of settlements
- Properly-timed PTO and ADR Proceedings
- How a redesign might solve your problems
The webinar will last one hour and will conclude with a live Q&A from the audience. For more event information and to register, click here.
For more than twenty years, Ed Mas’ practice has focused on complex patent and technology-related litigation. He has served as lead trial counsel in numerous patent infringement lawsuits from coast to coast and has been involved in multimillion dollar verdicts, awards, and settlements. Ed works with clients in a wide range of technologies, with a special emphasis on medical devices. One of his professional highlights includes securing a $166 million dollar victory for Advanced Cardiovascular Systems, which rates among the top patent damages awards of all time. More recently, Ed successfully defended multiple patent infringement suits on behalf of Abbott Laboratories, a leading global health care company, in which sales of the accused products exceeded $1 billion. Ed is repeatedly recognized as a Leading Lawyer in Illinois, and was featured in the inaugural IAM 1000: The World’s Leading Patent Practitioners. In addition to medical devices, Ed’s litigation practice also involves such diverse technologies as pharmaceuticals, biologics, barcode scanners and printers, bicycle equipment, and automotive sensors. As a registered patent attorney, Ed also handles patent reexaminations, IPRs, and other proceedings in the United States Patent and Trademark Office.
Leland Hansen has extensive experience in intellectual property litigation involving patents, trademarks, copyrights, trade secrets, unfair competition, and antitrust claims. Leland has served as lead counsel before federal district courts, the International Trade Commission, and the Federal Circuit Court of Appeals, and in contested proceedings at the United States Patent and Trademark Office, including reexamination and inter partes review. Leland also has served as lead counsel in the context of alternative dispute resolution such as mediation and binding arbitration, both domestically and internationally. In addition, Leland advises clients on transactional matters such as contract negotiation and due diligence for mergers and acquisitions and assists clients in valuing intellectual property portfolios and in strategic planning for portfolio development. Leland’s practice spans a wide variety of technologies including medical devices, biopharmaceuticals, angioplasty catheters and stents, antibody engineering, surgical equipment, nutritional supplements, contraceptive devices, cell expression systems, air conditioning equipment, cable modems, broadband communications, truck trailers, hearing aids, papermaking machines, railcars, refuse collection vehicles, and combustion systems.